iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in iTeos Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +4 vs. Q1 2024
- Shares held
- 36.2M
- +1.64M (+4.8%) vs. Q1 2024
- Total value
- $536.8M
- +$65.9M (+14.0%) vs. Q1 2024
- New holders
- 23
- 50 more added
- Sold out
- 19
- 44 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 109,075 | $1.62M | 0.00% | +83,872+332.8% | Added |
| Victory Capital Management Inc | 110,389 | $1.64M | 0.00% | +16,629+17.7% | Added |
| Bank of New York Mellon Corp | 121,250 | $1.80M | 0.00% | +5,409+4.7% | Added |
| Barclays PLC | 122,275 | $1.81M | 0.00% | −224,144−64.7% | Reduced |
| Panagora Asset Management Inc | 131,553 | $1.95M | 0.01% | +10,787+8.9% | Added |
| Algert Global LLC | 133,409 | $1.98M | 0.07% | +6,139+4.8% | Added |
| DAFNA Capital Management LLC | 144,360 | $2.14M | 0.51% | +45,800+46.5% | Added |
| Kennedy Capital Management, Inc. | 150,250 | $2.23M | 0.05% | +4,516+3.1% | Added |
| Clearline Capital LP | 156,894 | $2.33M | 0.20% | +156,894 | New |
| Jane Street Group, LLC | 159,855 | $2.37M | 0.00% | +159,855 | New |
| Eagle Asset Management Inc | 164,232 | $2.47M | 0.01% | −69,352−29.7% | Reduced |
| Jacobs Levy Equity Management, Inc | 176,314 | $2.62M | 0.01% | −328,231−65.1% | Reduced |
| Charles Schwab Investment Management Inc | 213,738 | $3.17M | 0.00% | +7,873+3.8% | Added |
| D. E. Shaw & Co., Inc. | 219,323 | $3.25M | 0.00% | +82,603+60.4% | Added |
| Prudential Financial Inc | 230,491 | $3.42M | 0.01% | −11,400−4.7% | Reduced |
| Millennium Management LLC | 241,305 | $3.58M | 0.00% | −641,676−72.7% | Reduced |
| Northern Trust Corp | 241,555 | $3.58M | 0.00% | −8,247−3.3% | Reduced |
| K2 Principal Fund, L.P. | 257,080 | $3.82M | 0.84% | +237,080+1,185.4% | Added |
| Nuveen Asset Management, LLC | 358,171 | $5.32M | 0.00% | −12,930−3.5% | Reduced |
| Saturn V Capital Management LLC | 367,429 | $5.45M | 2.06% | −19,666−5.1% | Reduced |
| JPMorgan Chase & Co | 461,951 | $6.86M | 0.00% | +444,193+2,501.4% | Added |
| Candriam Luxembourg S.C.A. | 509,303 | $7.56M | 0.05% | +509,303 | New |
| Renaissance Technologies LLC | 559,600 | $8.30M | 0.01% | −157,700−22.0% | Reduced |
| Geode Capital Management, LLC | 620,258 | $9.21M | 0.00% | +36,738+6.3% | Added |
| Citadel Advisors LLC | 697,332 | $10.3M | 0.01% | −471,332−40.3% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 723,000 | $10.7M | 0.18% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 732,272 | $10.9M | 0.00% | +16,015+2.2% | Added |
| Dimensional Fund Advisors LP | 908,329 | $13.5M | 0.00% | +117,159+14.8% | Added |
| State Street Corp | 963,901 | $14.3M | 0.00% | +386,356+66.9% | Added |
| Morgan Stanley | 1,089,299 | $16.2M | 0.00% | −543,057−33.3% | Reduced |
| 683 Capital Management, LLC | 1,115,000 | $16.5M | 1.74% | +400,000+55.9% | Added |
| MPM Oncology Impact Management LP | 1,745,943 | $25.9M | 4.03% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 1,750,000 | $26.0M | 1.94% | +1,750,000 | New |
| Vanguard Group Inc | 2,050,006 | $30.4M | 0.00% | +549,404+36.6% | Added |
| MPM Asset Management LLC | 2,738,785 | $40.6M | 22.32% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,946,915 | $43.7M | 2.30% | +1,142,857+63.3% | Added |
| EcoR1 Capital, LLC | 3,249,835 | $48.2M | 1.48% | +1,250,586+62.6% | Added |
| Ra Capital Management, L.P. | 3,517,259 | $52.2M | 0.69% | −900,000−20.4% | Reduced |
| BlackRock Inc. | 3,731,036 | $55.4M | 0.00% | −383,784−9.3% | Reduced |
| Braidwell LP | 0 | $0 | 0.00% | −1,162,374−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −244,712−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −103,981−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −75,678−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −50,936−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,886−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −24,473−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −20,542−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −20,312−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −17,635−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −17,428−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −15,451−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −12,213−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,614−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −3,383−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,373−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,365−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,233−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |